Furosemide and Cross-Reactivity with Sulfa-Containing Antibiotics

Additional relevant references:

Furosemide and cross-reactivity with sulfa-containing antibiotics

Original reports

1) Ahmad A, Ramakrishnan A, McLean MA et al (2002) Use

of optical biosensor technology to study immunological cross-reactivity between differen

t sulfonamide drugs. Anal Biochem 300:177–184

2) Bigby M, Jick S, Jick H et al (1986) Drug-induced cutaneous reactions. A report from the

Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975

to 1982. JAMA 256:3358–3363

3) Lowe J, Gray J, Henry DA et al (1979) Adverse reactions to frusemide in hospital

inpatients. Br Med J 2:360–362

4) Murray MD, Deer MM, Ferguson JA et al (2001) Open-label randomized trial

of torsemide compared with furosemide therapy for patients with heart failure. Am J Med

111:513–520

5) Ramsay LE, McInnes GT, Hettiarachchi J et al (1978) Bumetanide and frusemide: a

comparison of dose-response curves in healthy men. Br J Clin Pharmacol 5:243–247

6) Sfakianakis GN, Sfakianaki E, Georgiou M et al (2009) A renal protocol for all ages and

all indications -- mercapto-acetyl-triglycine (MAG3) with simultaneous injection of

furosemide (MAG3-F0): a 17-year experience. Semin Nucl Med 39:156–173

7) Tuzel IH (1981) Comparison of adverse reactions to bumetanide and furosemide. J Clin

Pharmacol 21:615–619

Reviews

of 5 8) Asbury MJ, Gatenby PBB, O’Sullivan S et al (1972) Bumetanide: potent new ‘loop’

diuretic. Br Med J 1:211–213

9) DiNocolantionio JJ (2012) Should torsemide be the loop diuretic of choice in systolic

heart failure? Future Cardiol 8:707–728

10) Halstenson CE, Matzke GR (1983) Bumetanide: a new loop diuretic (Bumex, Roche

Laboratories). Drug Intell Clin Pharm 17):786–797

11) Molnar J, Somberg JC (2009) The clinical pharmacology of ethacrynic acid. Am J Ther

16:86–92

12) Somberg JC, Molnar J (2009) The management of acute heart

failure and diuretic therapy. Am J Ther 16:93–97

Case reports

13) Earl G, Davenport J, Narula J (2003) Furosemide challenge in patients with heart failure

and adverse reactions to sulfa-containing diuretics. Ann Intern Med 138:358–359

14) Nguyen BD, Roarke MC, Howard OH (2010) Ethacrynic acid as potential drug for

diuretic renography in instance of sulfonamide allergy. Clin Nucl Med 35:547–549

15) Wall GC, Bigner D, Craig S (2003) Ethacrynic acid and the sulfa sensitive patient. Arch

Intern Med 163:116–117

Case series of furosemide allergy

16) Buchanan N, Cane RD (1977) Frusemid-induced [sic] pancreatitis. Br Med J 2:1417

17) Burry JN, Lawrence JR (1976) Phototoxic blisters from high frusemide dosage. Br J

Dermatol 94:495–499

of 5 18) Kennedy AC, Lyell A (1976) Acquired epidermolysis bullosa due to high-dose

frusemide. Br Med J 1:1509–1510

19) Machtey I (1968) Sudden death after intramuscular frusemide. Lancet 2:1301

20) Panayiotou BN, Prasad MV, Zaman MN (1997) Frusemide-induced bullous pemphigoid.

Br J Clin Pract 51:49–50

21) Siddigui MA, Zaman MN (1995) Recurrent and chronic leg ulcers secondary to

furosemide-induced bullous pemphigoid. J Am Geriatr Soc 43:1183–1184

22) Strunge P (1975) Letter: frusemide-induced pancreatitis? Br Med J 3:434

Case reports of furosemide allergy

23) Alim N, Patel JY (2009) Rapid oral desensitization to furosemide. Ann Allergy Asthma

Immunol 103:538

24) Baz K, Ikizoglu G, Kaya TI et al (2002) Furosemide-induced bullous pemphigoid. J Eur

Acad Dermatol Venereol 16:81–82

25) Call T, Malarkey WB, Thomas FB (1977) Acute pancreatitis secondary to furosemide

with associated hyperlipidemia. Am J Dig Dis 22:835–838

26) Castel T, Gratacos R, Castro J et al (1981) Bullous pemphigoid induced by furosemide.

Clin Exp Dermatol 6:635–638

27) Cobb MW (1989) Furosemide-induced eruption simulating Sweet's syndrome. J Am

Acad Dermatol 21:339–343

28) Dagli AJ, Moos JS (1983) Sudden death following injection of frusemide: a case report.

Indian J Med Sci 38:49–50

of 5 29) Dominguez-Ortega J, Martinez-Alonso JC, Dominguez-Ortega C et al (2003)

Anaphylaxis to oral furosemide. Allergol Immunopathol 31:345–347

30) Ebringer A, Adam WR, Parkin JD (1969) Bullous haemorrhagic eruption associated with

frusemide. Med J Aust 1:768–771

31) Fellner MJ, Katz JM (1976) Occurrence of bullous pemphigoid after furosemide therapy.

Arch Dermatol 112:75–77

32) Gibson TP, Blue P (1970) Erythema multiforme and furosemide therapy. JAMA

212:1709

33) Guin JD (1980) Bullous haemorrhagic eruption: a drug-induced disease. Cutis 25:534–

34) Hansbrough JR, Wedner HJ, Chaplin DD (1987) Anaphylaxis to intravenous furosemide.

J Allergy Clin Immunol 80:538–541

35) Hendericks WM, Ader RS (1977) Furosemide-induced cutaneous necrotizing vasculitis.

Arch Dermatol 113:375

36) Jones PE, Oelbaum MH (1975) Frusemide-induced pancreatitis. Br Med J 1:133–134

37) Juang P, Page RL 2nd, Zolty R (2006) Probable loop diuretic-induced pancreatitis in a

sulfonamide-allergic patient. Ann Pharmacother 40:128–134

38) Koch CA, Mazzaferri EL, Larry JA et al (1996) Bullous pemphigoid after treatment with

furosemide. Cutis 58:340–344

39) Lee JJ, Downham TF 2nd (2006) Furosemide-induced bullous pemphigoid: case report

and review of literature. J Drugs Dermatol 5:562–564

40) Macmillan AL (1973) Generalised pustual drug rash. Dermatologica 146:285–291

of 5 41) Noce R, Paredes BE, Pichler WJ et al (2000) Acute generalized exanthematic pustulosis

(AGEP) in a patient treated with furosemide. Am J Med Sci 320:331–333

42) Steinvinkel P, Alvestrand A (1988) Loop diuretic-induced pancreatitis with rechallenge

in a patient with malignant hypertension and renal insufficiency. Acta Med Scand

224:89–91

43) Sugita K, Kabashima K, Nakashima D et al (2008) Papuloerythroderma of Ofuji induced

by furosemide. J Am Acad Dermatol 58:S54–55

44) Takeichi S, Kubo Y, Arase S et al (2009) Brunsting-Perry type

localized bullous pemphigoid, possibly induced by furosemide administration and sun

exposure. Eur J Dermatol 19:500–503

45) Wilson AE, Mehra SK, Gomersall CR et al (1967) Acute pancreatitis associated with

frusemide therapy. Lancet 1:105

46) Wright AA, Vesta KS, Stark JE et al (2010) Stevens-Johnson syndrome associated with

furosemide: a case report. J Pharm Pract 23:367–370

47) Zugerman C, La Voo EJ (1980) Erythema multiforme caused by oral furosemide. Arch

Dermatol 116:518–519